Form EFFECT Qualigen Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 19, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SEABOURN INTRODUCES A CULINARY PHILOSOPHY BRINGING DESTINATIONS TO LIFE THROUGH FOOD, FLAVOR AND DISCOVERY
- Metro Development Group Breaks Ground on 1,100-Acre Sunrise Hills Community in Brooksville
- Dealpath Launches Dealpath MCP, Connecting Investment Teams’ AI to Live Market Opportunities and Proprietary Investment Intelligence
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share